Loading...
Loading...
India's serum imports from UNITED STATES total $64.3B across 3,283 shipments from 15 foreign suppliers. Takeda Pharmaceuticals International AG leads with $51.9B in import value; the top 5 suppliers together control 99.9% of this origin. Leading Indian buyers include TAKEDA BIOPHARMACEUTICALS INDIA PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for serum โ a diversified sourcing base with multiple active suppliers from UNITED STATES.

Takeda Pharmaceuticals International AG is the leading Serum supplier from UNITED STATES to India, with import value of $51.9B across 97 shipments. The top 5 suppliers โ Takeda Pharmaceuticals International AG, GRIFOLS WORLDWIDE OPERATION LTD., M/S. ADMA BIOLOGICS, INC, GRIFOLS WORLDWIDE OPERATION LIMITED, LIFE TECHNOLOGIES CORPORATION โ collectively account for 99.9% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | Takeda Pharmaceuticals International AG | $51.9B | 97 | 80.8% |
| 2 | GRIFOLS WORLDWIDE OPERATION LTD. | $10.2B | 28 | 15.9% |
| 3 | M/S. ADMA BIOLOGICS, INC | $1.8B | 15 | 2.8% |
| 4 | GRIFOLS WORLDWIDE OPERATION LIMITED | $192.6M | 5 | 0.3% |
| 5 | LIFE TECHNOLOGIES CORPORATION | $70.5M | 84 | 0.1% |
| 6 | PROLIANT BIOLOGICALS LLC | $12.1M | 6 | 0.0% |
| 7 | M S ADMA BIOLOGICS INC | $10.4M | 1 | 0.0% |
| 8 | TAKEDA PHARMACEUTICALS INTERNATIONAL AG. | $5.0M | 17 | 0.0% |
| 9 | LIFE TECHNOLOGIES CORPORATION... | $2.8M | 84 | 0.0% |
| 10 | BIO-RAD LABORATORIES | $2.8M | 10 | 0.0% |
| 11 | TAKEDA PHARMACEUTICALS INTERNATIONAL AG | $2.7M | 8 | 0.0% |
| 12 | MS KEDRION BIOPHARMA INC | $1.5M | 3 | 0.0% |
| 13 | M/S. KEDRION BIOPHARMA, INC | $1.4M | 3 | 0.0% |
| 14 | BIOIVT. | $726.5K | 1 | 0.0% |
| 15 | SIGMA ALDRICH CO LLC | $638.4K | 14 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | TAKEDA BIOPHARMACEUTICALS INDIA PRIVATE LIMITED | $51.6B | 88 | 80.3% |
| 2 | GRIFOLS INDIA HEALTHCARE PRIVATE LIMITED | $10.4B | 34 | 16.2% |
| 3 | RELIANCE LIFE SCIENCES PRIVATE LIMITED | $1.8B | 26 | 2.8% |
| 4 | BAXALTA BIOSCIENCE INDIA PRIVATE LIMITED | $357.8M | 34 | 0.6% |
| 5 | INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED | $73.3M | 200 | 0.1% |
| 6 | DK ENZYMES AND CHEMICALS | $12.2M | 7 | 0.0% |
| 7 | BIO-RAD LABORATORIES (INDIA) PRIVATE LIMITED | $2.8M | 10 | 0.0% |
| 8 | IMMUNOADOPTIVE CELL THERAPY PRIVATE LIMITED | $822.5K | 10 | 0.0% |
| 9 | SYNGENE INTERNATIONAL LIMITED | $668.8K | 380 | 0.0% |
| 10 | SIGMA ALDRICH CHEMICALS PRIVATE LIMITED | $585.5K | 73 | 0.0% |
| 11 | CORNING TECHNOLOGIES INDIA PRIVATE LIMITED | $397.0K | 33 | 0.0% |
| 12 | MERCK LIFE SCIENCE PRIVATE LIMITED | $394.1K | 709 | 0.0% |
| 13 | ESCIENTIA LABORATORY ESSENTIALS PRIVATE LIMITED | $363.6K | 1 | 0.0% |
| 14 | SIGMA ALDRICH CHEMICALS P LTD | $274.9K | 3 | 0.0% |
| 15 | BHARAT SERUMS AND VACCINES LIMITED | $222.5K | 4 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Serum suppliers from UNITED STATES to India include Takeda Pharmaceuticals International AG, GRIFOLS WORLDWIDE OPERATION LTD., M/S. ADMA BIOLOGICS, INC. The leading supplier is Takeda Pharmaceuticals International AG with import value of $51.9B USD across 97 shipments. India imported Serum worth $64.3B USD from UNITED STATES in total across 3,283 shipments.
India imported Serum worth $64.3B USD from UNITED STATES across 3,283 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Serum sourced from UNITED STATES include TAKEDA BIOPHARMACEUTICALS INDIA PRIVATE LIMITED, GRIFOLS INDIA HEALTHCARE PRIVATE LIMITED, RELIANCE LIFE SCIENCES PRIVATE LIMITED. The largest buyer is TAKEDA BIOPHARMACEUTICALS INDIA PRIVATE LIMITED with $51.6B in imports across 88 shipments.
The total value of Serum imports from UNITED STATES to India is $64.3B USD, across 3,283 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,283 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists